» Articles » PMID: 3360784

Transcriptional Regulation of Ceruloplasmin Gene Expression During Inflammation

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1988 May 5
PMID 3360784
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Mixed sequence oligonucleotides were used to isolate a series of acute-phase human liver cDNA clones corresponding to the serum alpha 2-globulin ceruloplasmin. These clones were characterized, sequenced, and used to analyze changes in hepatic ceruloplasmin mRNA content during inflammation. In all species examined, hepatic ceruloplasmin mRNA content increased approximately 6-10-fold over control values within 24 h following the induction of inflammation. The mechanisms leading to this increase in hepatic ceruloplasmin mRNA content were studied following turpentine-induced inflammation in Syrian hamsters. Nuclear run-on assays demonstrated an increase in the relative rate of transcription of the ceruloplasmin gene within 3 h following induction, reaching maximum values by 18 h. Hepatic ceruloplasmin mRNA content increased 2-fold within 12 h following induction, reached maximum values by 24 h, and returned to control within 72 h. In contrast, serum ceruloplasmin concentration did not increase until 36 h, reached maximal levels by 120 h, and remained elevated for the course of the study. These data indicate that inflammation leads to a rapid increase in hepatic ceruloplasmin mRNA content. This increase is largely the result of increased ceruloplasmin gene transcription, but comparison of the relative rate of transcription and mRNA accumulation suggests that changes in ceruloplasmin mRNA turnover are also involved. In addition, translational and/or post-translational mechanisms must account for the observed changes in serum ceruloplasmin concentration seen during inflammation.

Citing Articles

Application of integrin subunit genes in pancreatic cancer and the construction of a prognosis model.

Ye Q, Zhou T, Liu X, Chen D, Yang B, Yu T J Gastrointest Oncol. 2024; 15(5):2286-2304.

PMID: 39554585 PMC: 11565112. DOI: 10.21037/jgo-24-612.


Diabetes and Renal Complications: An Overview on Pathophysiology, Biomarkers and Therapeutic Interventions.

Jha R, Lopez-Trevino S, Kankanamalage H, Jha J Biomedicines. 2024; 12(5).

PMID: 38791060 PMC: 11118045. DOI: 10.3390/biomedicines12051098.


Development of a New Colorimetric, Kinetic and Automated Ceruloplasmin Ferroxidase Activity Measurement Method.

Neselioglu S, Firat Oguz E, Erel O Antioxidants (Basel). 2022; 11(11).

PMID: 36358559 PMC: 9686494. DOI: 10.3390/antiox11112187.


Discovery of Schistosoma mekongi circulating proteins and antigens in infected mouse sera.

Uthailak N, Adisakwattana P, Thiangtrongjit T, Limpanont Y, Chusongsang P, Chusongsang Y PLoS One. 2022; 17(10):e0275992.

PMID: 36227939 PMC: 9562170. DOI: 10.1371/journal.pone.0275992.


Caught red handed: modeling and confirmation of the myeloperoxidase ceruloplasmin alpha-thrombin complex.

Zabrodskaya Y, Egorov V, Sokolov A, Shvetsov A, Gorshkova Y, Ivankov O Biometals. 2022; 35(6):1157-1168.

PMID: 35962914 PMC: 9375587. DOI: 10.1007/s10534-022-00432-2.